Evomet is a 4-year Innovative Training Networks Marie Skłodowska-Curie Action, supported by the European Commission, that aims to transform how cancer metastasis is understood and treated. The Evomet consortium is formed by 13 institutions, which include several of the best academic, clinical and industrial centres working in cancer research and metastasis research in Europe, and its goal is to train 15 young researchers.
Almirall, S.A. (ALM), a global biopharmaceutical company focused on skin health, and IRB Barcelona (the Institute for Research in Biomedicine), an independent, international research centre engaged in fundamental and applied biomedical science, announced today a research collaboration to identify new oral treatments for immune-inflammatory skin diseases with remaining high unmet medical needs using molecular glue degraders, a novel therapeutic modality.
Today, the European Research Council (ERC) has announced the award of its Starting Grants to 397 group leaders throughout Europe, 23 of them in Spain—of these 13 in Catalonia. Dr. Alejo Rodríguez-Fraticelli and Dr. Cristina Mayor-Ruiz, recently appointed by IRB Barcelona to set up their own groups, are among the beneficiaries.
The Gate2Brain-4-Cancer project “Crossing the blood-brain barrier to treat paediatric cancer”, linked to the technology developed by the spin-off Gate2Brain, has been awarded funding in the 2021 CaixaResearch Consolidate call run by ”la Caixa” Foundation. Through this award, ”la Caixa” Foundation will help the technology developed by Gate2Brain to progress and reach society, with the ultimate goal of enhancing the health and quality of life of children with brain tumours such as diffuse intrinsic pontine glioma (DIPG).
Last Friday, 17 December 2021, IRB Barcelona hosted the 6th edition of the IRB Barcelona Alumni Excellence Award, presented to Dr. Rosana Collepardo-Guevara, Interdisciplinary Lecturer in Genetics and Chemistry and Assistant Professor and Group Leader at the University of Cambridge.
Fungi of the Candida genus cause diseases such as vaginal candidiasis (highly prevalent but not serious) and systemic candidiasis (rare but can be fatal in immunocompromised patients). Although some treatments are available, these infections are becoming increasingly resistant to drugs, so finding new therapeutic approaches is crucial for global health.
The language in which the DNA book of life is written is still being deciphered, which is why it remains a challenge to translate what genes say into physical traits in the organism. For example, why does this or that mutation sometimes cause cancer, and sometimes not? Researchers at the CNIO, the CRG and the IRB Barcelona have just discovered one of the reasons: the power of a mutation depends on its interaction with another, and often even on the relationship between this pair of mutations with a third.
"I firmly believe a programme that takes such unparalleled care of the next generation of scientists is bound to fascinate any undergraduate like me interested in pursuing a scientific career."
"The programme is international, so it offers the possibility to open collaborations on a European level more easily. Also, IRB Barcelona has a very good research programme. The PIs who work at this institute are very known in the scientific community, in fact they attracted my attention. In general, IRB has a reputation in Spain but also in general at a European level."
"The research community at IRB Barcelona fosters such a collaborative environment, not only intra-institution but also inter-institution with the various individual institutes in the PCB, BIST, and Barcelona. This close collaboration not only makes it easier to reach out to experts across the field and do interdisciplinary science but also includes various learning experiences that could be helpful during my academic career."